Drug Type Monoclonal antibody |
Synonyms MSM 735, MSM735 |
Target |
Mechanism CCR7 inhibitors(C-C motif chemokine receptor 7 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | US | 30 Jan 2022 | |
Idiopathic Pulmonary Fibrosis | Preclinical | US | 30 Jan 2022 | |
Melanoma | Preclinical | US | 30 Jan 2022 | |
Metastatic Solid Tumor | Preclinical | US | 30 Jan 2022 | |
Multiple Sclerosis | Preclinical | US | 30 Jan 2022 | |
Pancreatic Cancer | Preclinical | US | 30 Jan 2022 | |
Stomach Cancer | Preclinical | US | 30 Jan 2022 |